VOYA Investment Management
VOR icon

VOYA Investment Management’s Vor Biopharma VOR Stock Holding History

VOYA Investment Management’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-733
Closed -$34.8K – 2909
2024
Q1 		$34.8K Sell
733
-62
-8% -$2.72K ﹤0.01% 2755
2023
Q4 		$35.8K Hold
795
– – ﹤0.01% 2878
2023
Q3 		$33.7K Hold
795
– – ﹤0.01% 2882
2023
Q2 		$49.1K Buy
+795
New +$72.6K ﹤0.01% 2902
2021
Q2 		– Sell
-237
Closed -$204K – 2905
2021
Q1 		$204K Buy
+237
New +$201K ﹤0.01% 2539

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VOYA Investment Management's VOR Position: Q2 2024 in Review

VOYA Investment Management sold out of Vor Biopharma (VOR) in Q2 2024, closing a stake of 733 shares — an estimated $34.8K sold.

VOYA Investment Management first reported a position in VOR in Q1 2021 and held it in 5 quarters. The position peaked at $204K in Q1 2021. 71 funds tracked by Wall St. Rank hold VOR as of Q2 2024.

  • VOYA Investment Management reported no remaining Vor Biopharma position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 733 Vor Biopharma shares in Q2 2024, an estimated $34.8K.
  • VOYA Investment Management first reported a position in Vor Biopharma in Q1 2021 and held it in 5 quarters.
  • VOYA Investment Management's Vor Biopharma position peaked at $204K in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.